"MOORE Clinical Research, Inc. is a privately owned and operated clinical research clinic founded in 2006 with three convenient locations around Tampa Bay. Participation in a clinical trial allows patients to play a more active role in their own health care, gain access to new research treatments before they are widely available, and help others by contributing to medical research. Every medication used in treatment today once started as a clinical trial."

During the past decade, MOORE Clinical Research, Inc. conducted 39 clinical trials. In the 10-year time frame, 39 clinical trials started and 19 clinical trials were completed, i.e. on average, 48.7% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 15 clinical trials were completed. i.e. 83.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "MOORE Clinical Research, Inc." #1 sponsor was "Pfizer" with 7 trials, followed by "Actavis Inc." with 4 trials sponsored, "DUSA Pharmaceuticals, Inc." with 3 trials sponsored, "Dermira, Inc." with 3 trials sponsored and "Cassiopea SpA" with 3 trials sponsored. Other sponsors include 17 different institutions and companies that sponsored additional 26 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "MOORE Clinical Research, Inc." #1 collaborator was "Novum Pharmaceutical Research Services" with 3 trials as a collaborator, "ACM Global Laboratories" with 2 trials as a collaborator, "bioRASI, LLC" with 2 trials as a collaborator, "Accelovance" with 1 trials as a collaborator and "Catawba Research" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "MOORE Clinical Research, Inc." are "Acne Vulgaris" (9 trials), "Actinic Keratosis" (5 trials), "Plaque Psoriasis" (5 trials), "Atopic Dermatitis" (4 trials) and "COVID-19" (4 trials). Many other conditions were trialed in "MOORE Clinical Research, Inc." in a lesser frequency.

Most popular intervention types in "MOORE Clinical Research, Inc." are "Drug" (37 trials), "Other" (7 trials), "Biological" (4 trials), "Device" (3 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "PF-07321332" (3 trials), "Ritonavir" (3 trials), "Topical Solution Vehicle" (3 trials) and "Vehicle" (3 trials). Other intervention names were less common.

The vast majority of trials in "MOORE Clinical Research, Inc." are 40 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "MOORE Clinical Research, Inc.". undefined are not yet recruiting, 2 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 34 completed trials in MOORE Clinical Research, Inc., undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in MOORE Clinical Research, Inc., 2 "Phase 1" clinical trials were conducted, 17 "Phase 2" clinical trials and 23 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".